| ALGERNON HEALTH INC. A |
| Kanada |
| Gesundheit |
| CA01559C1068 / A41QK7 |
| AGW2 (Frankfurt) |
| FRA:AGW2, ETR:AGW2, AGW2:GR |
| - |
| https://www.algernonhealt.. |
|
Algernon Health Inc. is a clinical-stage biotechnology company specializing in the development of repurposed therapeutic drugs targeting serious medical conditions such as non-alcoholic steatohepatitis (NASH), chronic kidney disease, inflammatory bow..
>Volltext.. |
| 1.45 Mio. EUR |
| 1.94 Mio. EUR |
| - |
| -1.15 Mio. EUR |
| -1.2 Mio. EUR |
| -0.04 EUR |
| - |
| 0.13 Mio. EUR |
| -0.79 Mio. EUR |
| 0.09 |
| - |
| -387.27% |
| - |
| - |
| - |
| - |
| ALGERNON HEALTH |
| 05.04.26 |
|